Cooccurring JAK2 V617F and R1063H mutations increase JAK2 signaling and neutrophilia in myeloproliferative neoplasms

被引：6

作者：

Mambet, Cristina ^{[1
,2
,3
]}

Babosova, Olga ^{[4
]}

Defour, Jean-Philippe ^{[2
,5
]}

Leroy, Emilie ^{[1
,2
]}

Necula, Laura ^{[3
]}

Stanca, Oana ^{[6
,7
]}

Tatic, Aurelia ^{[7
,8
]}

Berbec, Nicoleta ^{[6
,7
]}

Coriu, Daniel ^{[7
,8
]}

Belickova, Monika ^{[9
]}

Kralova, Barbora ^{[10
]}

Lanikova, Lucie ^{[4
]}

Vesela, Jitka ^{[9
]}

Pecquet, Christian ^{[1
,2
]}

Saussoy, Pascale ^{[5
]}

Havelange, Violaine ^{[11
]}

Diaconu, Carmen C. ^{[3
]}

Divoky, Vladimir ^{[10
]}

Constantinescu, Stefan N. ^{[1
,2
,3
]}

机构：

[1] Ludwig Inst Canc Res, Brussels Branch, Brussels, Belgium

[2] Catholic Univ Louvain, de Duve Inst, Brussels, Belgium

[3] Stefan S Nicolau Inst Virol, Mol Profiling Myeloproliferat Neoplasms & Acute L, Bucharest, Romania

[4] Acad Sci Czech Republ, Inst Mol Genet, Dept Cell & Dev Biol, Prague, Czech Republic

[5] Catholic Univ Louvain, Clin Univ St Luc, Dept Biol Clin, Brussels, Belgium

[6] Coltea Clin Hosp, Dept Hematol, Bucharest, Romania

[7] Carol Davila Univ Med & Pharm, Dept Radiol Oncol & Hematol, Bucharest, Romania

[8] Fundeni Clin Inst, Ctr Hematol & Bone Marrow Transplantat, Bucharest, Romania

[9] Inst Hematol & Blood Transfus, Prague, Czech Republic

[10] Palacky Univ, Fac Med & Dent, Dept Biol, Hnevotinska 3, CZ-77515 Olomouc, Czech Republic

[11] Clin Univ St Luc, Serv Hematol, Brussels, Belgium

来源：

BLOOD | 2018年 / 132卷 / 25期

关键词：

ESSENTIAL THROMBOCYTHEMIA; POLYCYTHEMIA-VERA;

D O I：

10.1182/blood-2018-04-843060

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：2695 / 2699

页数：7

共 50 条

[1] Quantitative assessment of JAK2 V617F and CALR mutations in Philadelphia negative myeloproliferative neoplasms
Gango, Ambrus
Mozes, Reka
Boha, Zsofia
Kajtar, Bela
Timar, Botond
Kiraly, Peter Attila
Kiss, Richard
Fesus, Viktoria
Nagy, Noemi
Demeter, Judit
Korosmezey, Gabor
Borbenyi, Zita
Marton, Imelda
Szoke, Anita
Masszi, Tamas
Farkas, Peter
Varkonyi, Judit
Plander, Mark
Posfai, Eva
Egyed, Miklos
Pal, Katalin
Radvanyi, Gaspar
Hamed, Aryan
Csomor, Judit
Matolcsy, Andras
Alpar, Donat
Bodor, Csaba
LEUKEMIA RESEARCH, 2018, 65 : 42 - 48
[2] Coexistence of lymphoproliferative and myeloproliferative neoplasms with simultaneous CALR and JAK2 V617F mutations
Yang, Hai-Su
CANCER BIOMARKERS, 2016, 17 (04) : 383 - 389
[3] CALR mutations in a cohort of JAK2 V617F negative patients with suspected myeloproliferative neoplasms
Mikic, Tanja Belcic
Pajic, Tadej
Sever, Matjaz
SCIENTIFIC REPORTS, 2019, 9 (1)
[4] JAK2 V617F Mutation Prevalence in Myeloproliferative Neoplasms in Pernambuco, Brazil
da Silva, Rafael Ramos
Domingues Hatzlhofer, Betania Lucena
de Faria Machado, Cintia Gonsalves
de Melo Lima, Aleide Santos
de Albuquerque, Dulcineia Martins
Nunes dos Santos, Magnun Nueldo
Fertrin, Kleber Yotsumoto
Costa, Fernando Ferreira
Araujo, Aderson da Silva
Cavalcanti Bezerra, Marcos Andre
GENETIC TESTING AND MOLECULAR BIOMARKERS, 2012, 16 (07) : 802 - 805
[5] Analysis of JAK2 V617F mutation in Tunisian patients with myeloproliferative neoplasms
Chadi, Soumaya
Dhaouadi, Tarak
Sfar, Imen
Baccouche, Hela
Nabli, Rym
Ben Romdhane, Neila
Ben Abdallah, Taieb
Gorgi, Yousr
EUROPEAN JOURNAL OF INFLAMMATION, 2021, 19
[6] JAK2 V617F and beyond: role of genetics and aberrant signaling in the pathogenesis of myeloproliferative neoplasms
Oh, Stephen T.
Gotlib, Jason
EXPERT REVIEW OF HEMATOLOGY, 2010, 3 (03) : 323 - 337
[7] The V617F JAK2 mutation and the myeloproliferative disorders
Percy, MJ
McMullin, MF
HEMATOLOGICAL ONCOLOGY, 2005, 23 (3-4) : 91 - 93
[8] Detection of JAK2 V617F mutation increases the diagnosis of myeloproliferative neoplasms
Zhang, Shu-Peng
Li, Hui
Lai, Ren-Sheng
ONCOLOGY LETTERS, 2015, 9 (02) : 735 - 738
[9] The JAK2 V617F Mutation in Pediatric Myeloproliferative Neoplasms: How and When?
Langabeer, Stephen E.
Smith, Owen P.
McMahon, Corrina
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2014, 31 (02) : 138 - 139
[10] New advances in the role of JAK2 V617F mutation in myeloproliferative neoplasms
Zhang, Yongchao
Zhao, Yue
Liu, YuSi
Zhang, Minyu
Zhang, Jihong
CANCER, 2024, 130 (24) : 4229 - 4240

← 1 2 3 4 5 →